Joern Reiner Kraetzschmar

Title: Joern Reiner Kraetzschmar: Innovator in Platelet Aggregation Inhibition

Introduction

Joern Reiner Kraetzschmar is a notable inventor based in Berlin, Mexico. He has made significant contributions to the field of medical science, particularly in the area of platelet aggregation inhibition. With a total of 2 patents, his work has the potential to impact treatments for various health conditions.

Latest Patents

Kraetzschmar's latest patents include a groundbreaking invention related to collagen-induced platelet aggregation inhibitors. This invention provides a protein derived from Triatoma pallidipennis that inhibits collagen-induced platelet aggregation. The protein is particularly useful for inhibiting collagen-induced human platelet aggregation or for addressing cancer with metastatic tumor cells.

Career Highlights

Throughout his career, Joern Reiner Kraetzschmar has been associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to focus on innovative solutions that address critical health issues.

Collaborations

Kraetzschmar has collaborated with several esteemed colleagues, including Christiane Noeske-Jungblut and Bernard Jacques Haendler. These collaborations have further enriched his research and development efforts.

Conclusion

Joern Reiner Kraetzschmar is a distinguished inventor whose work in platelet aggregation inhibition holds promise for advancing medical treatments. His contributions continue to shape the landscape of medical innovation.